The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 19, 2018

Filed:

Sep. 22, 2016
Applicant:

Vbi Technologies, L.l.c., Uxbridge, MA (US);

Inventors:

Martin P. Vacanti, Manhattan, KS (US);

Charles A. Vacanti, Uxbridge, MA (US);

Assignee:

VBI Technologies, L.L.C., Uxbridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/407 (2015.01); C12N 5/074 (2010.01); C12N 5/071 (2010.01); C12N 5/0797 (2010.01); C12N 5/0789 (2010.01); C12N 5/0775 (2010.01); C12N 5/079 (2010.01); C12N 5/077 (2010.01); A61K 35/22 (2015.01); A61K 35/28 (2015.01); A61K 35/30 (2015.01); A61K 35/34 (2015.01); A61K 35/42 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/407 (2013.01); A61K 35/22 (2013.01); A61K 35/28 (2013.01); A61K 35/30 (2013.01); A61K 35/34 (2013.01); A61K 35/42 (2013.01); C12N 5/0607 (2013.01); C12N 5/0614 (2013.01); C12N 5/0618 (2013.01); C12N 5/0623 (2013.01); C12N 5/0647 (2013.01); C12N 5/0652 (2013.01); C12N 5/0658 (2013.01); C12N 5/0668 (2013.01); C12N 5/0669 (2013.01); C12N 5/0672 (2013.01); C12N 5/0688 (2013.01); A61K 2035/124 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/392 (2013.01); Y10T 436/101666 (2015.01); Y10T 436/25375 (2015.01);
Abstract

Subpopulations of spore-like cells expressing specific cell surface and gene expression markers are provided. In one embodiment, the cells express at least one cell surface or gene expression marker selected from the group consisting of Oct4, nanog, Zfp296, cripto, Gdf3, UtF1, Ecat1, Esg1, Sox2, Pax6, nestin, SCA-1, CD29, CD34, CD90, B1 integrin, cKit, SP-C, CC10, SF1, DAX1, and SCG10. Also provided are methods for purifying a subpopulation of spore-like cells of interest from a population of spore-like cells, and methods for inducing differentiation of the isolated spore-like cells into cells of endodermal, mesodermal or ectodermal origin. The spore-like cells can be used to generate cells originating from all three germ layers and can be used to treat a patient who has a deficiency of functional cells in any of a wide variety of tissues, including the retina, intestine, bladder, kidney, liver, lung, nervous system, or endocrine system.


Find Patent Forward Citations

Loading…